共 387 条
[1]
Arenal Á(2022)Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia J Am Coll Cardiol 79 1441-1453
[2]
Ávila P(1989)Activation patterns in healed experimental myocardial infarction Circ Res 65 1698-1709
[3]
Jiménez-Candil J(1988)Interaction of fiber orientation and direction of impulse propagation with anatomic barriers in anisotropic canine myocardium Circulation 78 1478-1494
[4]
Tercedor L(2018)Automated isochronal late activation mapping to identify deceleration zones: rationale and methodology of a practical electroanatomic mapping approach for ventricular tachycardia ablation Comput Biol Med 102 336-340
[5]
Calvo D(1998)Endocardial activation mapping of ventricular tachycardia in patients: first application of a 32-site bipolar mapping electrode catheter Circulation 98 2168-2179
[6]
Arribas F(2016)Substrate mapping for unstable ventricular tachycardia Heart Rhythm 13 569-583
[7]
Fernández-Portales J(2015)Substrate mapping and ablation for ventricular tachycardia: the LAVA approach J Cardiovasc Electrophysiol 26 464-471
[8]
Merino JL(2012)Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia Circulation 125 2184-2196
[9]
Hernández-Madrid A(2022)2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) Eur Heart J 43 3997-4126
[10]
Fernández-Avilés FJ(2019)2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias Europace 21 1143-1144